OMEPRAZOLE Side Effects

6976337-9 | Dilatation Intrahepatic Duct Acquired, Hepatotoxicity, Liver Function Test Abnormal, Venoocclusive Liver Disease
on Sep 06, 2010 Female patient from UNITED KINGDOM , 19 years of age, was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive liver disease. Omeprazole dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), CHLORPHENAMINE (View Chlorphenamine Review and Chlorphenamine Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ETOPOPHOS PRESERVATIVE FREE (4650 Mg) (View Etopophos Preservative Free Review and Etopophos Preservative Free Label ).

6973586-0 | Burning Mouth Syndrome, Rash
Patient was taking Omeprazole (View Usage). Patient had the following side effects: burning mouth syndrome, rash (What is rash?) on Aug 27, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 52 years of age, was diagnosed with gastrooesophageal reflux disease and. Omeprazole dosage: . During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6973585-9 | Burning Mouth Syndrome, Rash
Adverse event was reported on Aug 27, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED KINGDOM , 52 years of age, After Omeprazole was administered, patient had the following side effects: burning mouth syndrome, rash (What is rash?). During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6973555-0 | Alanine Aminotransferase Increased, Gamma-glutamyltransferase Increased, Renal Failure Acute
on Sep 03, 2010 Female patient from GERMANY , 69 years of age, weighting 158.7 lb, was diagnosed with prophylaxis, thrombocytopenia, hypertension, urinary tract infection (What is urinary tract infection?) and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, gamma-glutamyltransferase increased, renal failure acute. Omeprazole dosage: . During the same period patient was treated with DECORTIN (View Decortin Review and Decortin Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ). Patient was hospitalized.


6971007-5 | Cutaneous Lupus Erythematosus
on Aug 17, 2010 Female patient from UNITED KINGDOM , 60 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with Omeprazole (View Usage). Patient had the following side effects: cutaneous lupus erythematosus. Omeprazole dosage: . During the same period patient was treated with DOMPERIDONE (DOMPERIDONE) (View Domperidone (domperidone) Review and Domperidone (domperidone) Label ).

6970964-0 | Burning Mouth Syndrome, Rash
Patient was taking Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: burning mouth syndrome, rash (What is rash?) on Aug 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 52 years of age, was diagnosed with gastrooesophageal reflux disease and. Omeprazole dosage: . During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6970498-3 | Conjunctivitis, Oedema Mouth, Oral Disorder, Stevens-johnson Syndrome
Adverse event was reported on Aug 18, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: 20 Mg; Po, 20 Mg; Cap; Po) . Location: UNITED KINGDOM , 88 years of age, Patient experienced the following unwanted or unexpected effects: conjunctivitis, oedema mouth, oral disorder, stevens-johnson syndrome. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6969393-5 | Hypomagnesaemia
on Aug 25, 2010 Female patient from UNITED KINGDOM , 38 years of age, weighting 112.4 lb, was diagnosed with dyspepsia and was treated with Omeprazole (View Usage). Patient had the following side effects: hypomagnesaemia. Omeprazole dosage: 20 Mg, Oral. During the same period patient was treated with LANSOPRAZOLE (30 Mg, Oral) (View Lansoprazole Review and Lansoprazole Label ), CYCLIZINE (CYCLIZINE) (View Cyclizine (cyclizine) Review and Cyclizine (cyclizine) Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ).

6969101-8 | Coronary Artery Occlusion
on Sep 01, 2010 Male patient from JAPAN , 82 years of age, was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: coronary artery occlusion. Omeprazole dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6969020-7 | Femoral Neck Fracture, Hip Fracture
Patient was taking Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: femoral neck fracture, hip fracture on Sep 03, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, weighting 140.0 lb, was diagnosed with gastritis and. Omeprazole dosage: 40 Mg Day Po. Patient was hospitalized and became disabled.

6968760-3 | Chest Pain, Device Occlusion, Gastrointestinal Ulcer
Adverse event was reported on Aug 17, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: 20 Mg Once A Day, Oral) was diagnosed with prophylaxis against gastrointestinal ulcer, cardiac disorder and. Location: UNITED STATES , weighting 135.0 lb, Patient had the following side effects: chest pain (What is chest pain?), device occlusion, gastrointestinal ulcer. During the same period patient was treated with PLAVIX (75 Mg Once A Day, Oral) (View Plavix Review and Plavix Label ), AZOR (ALPRAZOLAM) (View Azor (alprazolam) Review and Azor (alprazolam) Label ), BYSTOLIC (View Bystolic Review and Bystolic Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), VITAMINS (View Vitamins Review and Vitamins Label ). Patient was hospitalized.

6967519-0 | Hepatitis
on Aug 31, 2010 Female patient from SINGAPORE , 61 years of age, was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: hepatitis (What is hepatitis?). Omeprazole dosage: . During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6965298-4 | Blood Potassium Decreased, Muscle Spasms, Oedema Peripheral, Palpitations, Paraesthesia
on Aug 27, 2010 Female patient from UNITED STATES , 40 years of age, weighting 150.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, muscle spasms, oedema peripheral, palpitations, paraesthesia. Omeprazole dosage: . Patient was hospitalized.

6964931-0 | Hypomagnesaemia
Patient was taking Omeprazole (View Usage). Patient had the following side effects: hypomagnesaemia on Aug 25, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 38 years of age, weighting 112.4 lb, was diagnosed with dyspepsia and. Omeprazole dosage: . During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ).

6960940-6 | Viith Nerve Paralysis
Adverse event was reported on Aug 20, 2010 by a Male patient taking Omeprazole (View Usage) (Dosage: 20 Mg Daily) was diagnosed with gastrointestinal inflammation, ear infection (What is ear infection?), acute leukaemia and. Location: BELGIUM , 13 years of age, weighting 134.5 lb, After Omeprazole was administered, patient had the following side effects: viith nerve paralysis. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (2x400 Mg Daily) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), METHYLPREDNISOLONE ACETATE (3 Mg) (View Methylprednisolone Acetate Review and Methylprednisolone Acetate Label ), THIOGUANINE (60mg/mm/day) (View Thioguanine Review and Thioguanine Label ), CYCLOPHOSPHAMIDE (1000 Mg/mm) (View Cyclophosphamide Review and Cyclophosphamide Label ), MESNA (1000 Mg/mm) (View Mesna Review and Mesna Label ), CYTARABINE (75 Mg/mm Per Day) (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized.

6958480-3 | Blood Glucose Increased
on Aug 27, 2010 Female patient from UNITED STATES , 74 years of age, weighting 110.0 lb, was diagnosed with dyspepsia and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased. Omeprazole dosage: 1 Twice Da..

6958224-5 | Tubulointerstitial Nephritis
on Aug 30, 2010 Male patient from UNITED STATES , 77 years of age, weighting 186.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Omeprazole (View Usage). Patient had the following side effects: tubulointerstitial nephritis. Omeprazole dosage: 20 Mg Am Po. Patient was hospitalized.

6956951-7 | Product Substitution Issue
Patient was taking Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: product substitution issue on Aug 27, 2010 from UNITED STATES Additional patient health information: Male patient , 79 years of age, . Omeprazole dosage: Take 1 Capsule Once Daily.

6956851-2 | Dysarthria, Haemoglobin Decreased, Hemiparesis, Platelet Count Decreased
Adverse event was reported on Aug 14, 2010 by a Male patient taking Omeprazole (View Usage) (Dosage: 20 Mg; Qd Po) was diagnosed with acute lymphocytic leukaemia and. Location: BELGIUM , 13 years of age, Patient experienced the following unwanted or unexpected effects: dysarthria, haemoglobin decreased, hemiparesis, platelet count decreased. During the same period patient was treated with CYCLOPHOSPHAMIDE (1000 Mg/m**2; Iv) (View Cyclophosphamide Review and Cyclophosphamide Label ), BACTRIM (400 Mg; Bid Po) (View Bactrim Review and Bactrim Label ), METHOTREXATE (12 Mg; Inth) (View Methotrexate Review and Methotrexate Label ), CYTARABINE (75 Mg/m**2; Iv) (View Cytarabine Review and Cytarabine Label ), TIOGUANINE (TIOGUANINE) (View Tioguanine (tioguanine) Review and Tioguanine (tioguanine) Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ASPARAGINASE (ASPARAGINASE) (View Asparaginase (asparaginase) Review and Asparaginase (asparaginase) Label ). Patient was hospitalized.

6955924-8 | Cystitis, Diarrhoea
on Aug 26, 2010 Female patient from UNITED STATES , 64 years of age, weighting 140.0 lb, was treated with Omeprazole (View Usage). Patient had the following side effects: cystitis, diarrhoea. Omeprazole dosage: .

6955916-9 | Cystitis, Diarrhoea, No Therapeutic Response
on Aug 26, 2010 Female patient from UNITED STATES , weighting 140.0 lb, was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: cystitis, diarrhoea, no therapeutic response. Omeprazole dosage: .

6946879-0 | Parotitis
Patient was taking Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: parotitis on Aug 10, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 74 years of age, was diagnosed with gastrooesophageal reflux disease and. Omeprazole dosage: 20 Mg Qd Po. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ALGINIC ACID (View Alginic Acid Review and Alginic Acid Label ), ALUMINIUN HYDROXIDE (View Aluminiun Hydroxide Review and Aluminiun Hydroxide Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), MAGNESIUM TRISILICATE (View Magnesium Trisilicate Review and Magnesium Trisilicate Label ), POTASSIUM BICARBONATE (View Potassium Bicarbonate Review and Potassium Bicarbonate Label ), SODIUM ALGINATE (View Sodium Alginate Review and Sodium Alginate Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ).

6946037-X | Anaphylactic Reaction, Skin Test Positive
Adverse event was reported on Aug 17, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: Oral) . Location: SPAIN , 42 years of age, Patient had the following side effects: anaphylactic reaction, skin test positive.

6944746-X | Conjunctivitis, Oedema Mouth, Oral Disorder, Skin Lesion, Stevens-johnson Syndrome
on Aug 18, 2010 Female patient from UNITED KINGDOM , 88 years of age, weighting 86.42 lb, was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: conjunctivitis, oedema mouth, oral disorder, skin lesion, stevens-johnson syndrome. Omeprazole dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SLOW K (View Slow-k Review and Slow-k Label ). Patient was hospitalized.

6943571-3 | Parotitis
on Aug 12, 2010 Female patient from UNITED KINGDOM , weighting 149.9 lb, was diagnosed with gastrooesophageal reflux disease, hypertension, atrial fibrillation (What is atrial fibrillation?) and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: parotitis. Omeprazole dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6943054-0 | Product Substitution Issue
Patient was taking Omeprazole (View Usage). Patient had the following side effects: product substitution issue on Aug 24, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 181.4 lb, . Omeprazole dosage: 20 Mg Bid Po.

6943014-X | Capsule Issue, Choking, Gastrooesophageal Reflux Disease, Nausea, Product Quality Issue
Adverse event was reported on Aug 25, 2010 by a Male patient taking Omeprazole (View Usage) (Dosage: 40 Mg Once Daily) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , weighting 245.0 lb, After Omeprazole was administered, patient had the following side effects: capsule issue, choking (What is choking?), gastrooesophageal reflux disease, nausea (What is nausea?), product quality issue.

6941420-0 | Dysarthria, Hemiparesis, Viith Nerve Paralysis
on Aug 11, 2010 Male patient from BELGIUM , 13 years of age, weighting 134.5 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: dysarthria, hemiparesis, viith nerve paralysis. Omeprazole dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE ((on Day 1)) (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (On Days 3-6 And 10-13) (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (On Day 3) (View Methotrexate Review and Methotrexate Label ), BACTRIM (View Bactrim Review and Bactrim Label ), DEXAMETHASONE (6 Mg/m2 Daily) (View Dexamethasone Review and Dexamethasone Label ), VINCRISTINE ((on Days 8, 15, 22, 29) Protocol Started On 2 June 2008) (View Vincristine Review and Vincristine Label ), DOXORUBICIN HCL (On Days 8, 15, 22, 29) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized.

6941419-4 | Dysarthria, Hemiparesis, Viith Nerve Paralysis
on Aug 11, 2010 Male patient from BELGIUM , 13 years of age, weighting 134.5 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Omeprazole (View Usage). Patient had the following side effects: dysarthria, hemiparesis, viith nerve paralysis. Omeprazole dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE ((on Day 1)) (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (On Days 3-6 And 10-13) (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (On Day 3) (View Methotrexate Review and Methotrexate Label ), BACTRIM (View Bactrim Review and Bactrim Label ), DEXAMETHASONE (6 Mg/m2 Daily) (View Dexamethasone Review and Dexamethasone Label ), VINCRISTINE ((on Days 8, 15, 22, 29) Protocol Started On 2 June 2008) (View Vincristine Review and Vincristine Label ), DOXORUBICIN HCL (On Days 8, 15, 22, 29) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized.

6940333-8 | Antinuclear Antibody Positive, Arthritis, Cardiolipin Antibody Positive, Lupus-like Syndrome, Oedema Peripheral, Raynaud's Phenomenon
Patient was taking Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: antinuclear antibody positive, arthritis (What is arthritis?), cardiolipin antibody positive, lupus-like syndrome, oedema peripheral, raynaud's phenomenon on Aug 04, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with reflux oesophagitis and. Omeprazole dosage: 20 Mg Qd Morning Dose.

6939446-6 | Bacterial Disease Carrier, Skin Exfoliation, Skin Infection
Adverse event was reported on Aug 02, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: (20 Mg Oral)) was diagnosed with gastrooesophageal variceal haemorrhage prophylaxis and. Location: UNITED KINGDOM , 53 years of age, Patient experienced the following unwanted or unexpected effects: bacterial disease carrier, skin exfoliation, skin infection.

6939422-3 | Electrocardiogram Abnormal, Giardiasis, Hypocalcaemia, Hypokalaemia, Hypomagnesaemia
on Aug 07, 2010 Female patient from NETHERLANDS , 62 years of age, was diagnosed with barrett's oesophagus and was treated with Omeprazole (View Usage). Patient had the following side effects: electrocardiogram abnormal, giardiasis, hypocalcaemia, hypokalaemia, hypomagnesaemia. Omeprazole dosage: 40 Mg;qd. During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

6936114-1 | Product Substitution Issue
on Aug 19, 2010 Female patient from UNITED STATES , 71 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: product substitution issue. Omeprazole dosage: Take 1 Capsule Twice Daily.

6935668-9 | Erythema, Skin Exfoliation, Staphylococcal Infection
Patient was taking Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, skin exfoliation, staphylococcal infection (What is staphylococcal infection?) on Aug 04, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 53 years of age, . Omeprazole dosage: 20 Mg Milligram(s) Oral.

6931234-X | Bacterial Disease Carrier, Skin Exfoliation
Adverse event was reported on Aug 02, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: 20 Mg Oral) was diagnosed with gastrooesophageal variceal haemorrhage prophylaxis and. Location: UNITED KINGDOM , 53 years of age, Patient had the following side effects: bacterial disease carrier, skin exfoliation.

6930269-0 | Bacterial Disease Carrier, Skin Exfoliation
on Aug 02, 2010 Female patient from UNITED KINGDOM , 53 years of age, was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: bacterial disease carrier, skin exfoliation. Omeprazole dosage: 20 Mg, Oral.

6930146-5 | Abdominal Distension, Flatulence, Weight Increased
on Aug 18, 2010 Female patient from UNITED STATES , 76 years of age, weighting 131.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, flatulence, weight increased. Omeprazole dosage: 20 Mg 2 A Day.

6929846-2 | Bacterial Disease Carrier, Skin Exfoliation
Patient was taking Omeprazole (View Usage). Patient had the following side effects: bacterial disease carrier, skin exfoliation on Aug 02, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 53 years of age, . Omeprazole dosage: 20 Mg;po.

6929659-1 | Antinuclear Antibody Increased, Arthralgia, Arthritis, Cardiolipin Antibody Positive, Erythema, Histone Antibody Positive, Joint Swelling, Lupus-like Syndrome, Malaise
Adverse event was reported on Aug 04, 2010 by a Male patient taking Omeprazole (View Usage) (Dosage: 20 Mg Qd, Morning Dose) was diagnosed with reflux oesophagitis and. Location: UNITED STATES , 63 years of age, After Omeprazole was administered, patient had the following side effects: antinuclear antibody increased, arthralgia, arthritis (What is arthritis?), cardiolipin antibody positive, erythema, histone antibody positive, joint swelling, lupus-like syndrome, malaise.

6928916-2 | Bacterial Disease Carrier, Skin Exfoliation
on Aug 03, 2010 Female patient from UNITED KINGDOM , 53 years of age, was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial disease carrier, skin exfoliation. Omeprazole dosage: .

6928911-3 | Electrocardiogram Abnormal, Hypocalcaemia, Hypokalaemia, Hypomagnesaemia
on Aug 03, 2010 Female patient from NETHERLANDS , 62 years of age, was diagnosed with barrett's oesophagus and was treated with Omeprazole (View Usage). Patient had the following side effects: electrocardiogram abnormal, hypocalcaemia, hypokalaemia, hypomagnesaemia. Omeprazole dosage: . During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

6922890-0 | Asthma, Breast Cancer, Hypercholesterolaemia, Weight Increased
Patient was taking Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: asthma (What is asthma?), breast cancer (What is breast cancer?), hypercholesterolaemia, weight increased on Aug 04, 2010 from BRAZIL Additional patient health information: Female patient , 50 years of age, weighting 165.3 lb, was diagnosed with gastrooesophageal reflux disease, hypercholesterolaemia, breast cancer (What is breast cancer?), asthma (What is asthma?) and. Omeprazole dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), NOLVADEX (View Nolvadex Review and Nolvadex Label ), FORASEQ (View Foraseq Review and Foraseq Label ). Patient was hospitalized.

6919862-9 | Blood Uric Acid Increased, Cold Sweat, Diarrhoea, Dyspnoea, Feeling Cold, Gastrooesophageal Reflux Disease, Headache, Hyperhidrosis, Hypophagia
Adverse event was reported on Aug 10, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: ) . Location: UNITED STATES , 83 years of age, weighting 141.0 lb, Patient experienced the following unwanted or unexpected effects: blood uric acid increased, cold sweat, diarrhoea, dyspnoea, feeling cold, gastrooesophageal reflux disease, headache (What is headache?), hyperhidrosis, hypophagia.

6918744-6 | Bacterial Disease Carrier, Skin Exfoliation
on Aug 02, 2010 Female patient from UNITED KINGDOM , 53 years of age, was treated with Omeprazole (View Usage). Patient had the following side effects: bacterial disease carrier, skin exfoliation. Omeprazole dosage: .

6917814-6 | Pathological Fracture
on Jul 26, 2010 Female patient from GERMANY , 79 years of age, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type), coronary artery disease (What is coronary artery disease?) and was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: pathological fracture. Omeprazole dosage: 40 Mg, 1 In 1 D, Oral. During the same period patient was treated with SIMVASTATIN (20 Mg, 1 In 1 D, Oral) (View Simvastatin Review and Simvastatin Label ), METOPROLOL SUCCINATE (47.5 Mg, 2 In 1 D, Oral) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCHLOROTHAZIDE (HYDROCHLOROTHIAZIDE) (View Hydrochlorothazide (hydrochlorothiazide) Review and Hydrochlorothazide (hydrochlorothiazide) Label ), CORIFEO 20 (LERCANIDIPINE HYDROCHLORIDE) (View Corifeo 20 (lercanidipine Hydrochloride) Review and Corifeo 20 (lercanidipine Hydrochloride) Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6917728-1 | Diarrhoea, Electrocardiogram Qt Prolonged, Electrocardiogram St Segment Depression, Giardiasis, Hypocalcaemia, Hypokalaemia, Hypomagnesaemia, Lymphangiectasia Intestinal
Patient was taking Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, electrocardiogram qt prolonged, electrocardiogram st segment depression, giardiasis, hypocalcaemia, hypokalaemia, hypomagnesaemia, lymphangiectasia intestinal on Jun 26, 2010 from NETHERLANDS Additional patient health information: Female patient , 62 years of age, was diagnosed with barrett's oesophagus and. Omeprazole dosage: Dose: 40 Mg Milligram(s) Sep. Dosages / Interval: 1 In 1 Day. During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

6914394-6 | Parotitis
Adverse event was reported on Jul 29, 2010 by a Female patient taking Omeprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease, atrial fibrillation (What is atrial fibrillation?), hypertension, coronary artery disease (What is coronary artery disease?) and. Location: UNITED KINGDOM , weighting 149.9 lb, Patient had the following side effects: parotitis. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ).

6911432-1 | Electrocardiogram Qt Prolonged, Electrocardiogram St Segment Depression, Hypocalcaemia, Hypokalaemia, Hypomagnesaemia
on Jul 28, 2010 Female patient from NETHERLANDS , 62 years of age, was diagnosed with barrett's oesophagus and was treated with Omeprazole (View Usage). After Omeprazole was administered, patient had the following side effects: electrocardiogram qt prolonged, electrocardiogram st segment depression, hypocalcaemia, hypokalaemia, hypomagnesaemia. Omeprazole dosage: 40 Mg/day. During the same period patient was treated with RABEPRAZOLE SODIUM (Unk) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

6899095-5 | Pathological Fracture
on Jul 19, 2010 Female patient from GERMANY , 79 years of age, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type), coronary artery disease (What is coronary artery disease?) and was treated with Omeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: pathological fracture. Omeprazole dosage: . During the same period patient was treated with METOPROLOL SUCCINATE (Daily Dose: 95 Mg Millgram(s) Every Days) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HCT (View Hct Review and Hct Label ), CORIFEO (View Corifeo Review and Corifeo Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6899094-3 | Pathological Fracture
Patient was taking Omeprazole (View Usage). Patient had the following side effects: pathological fracture on Jul 19, 2010 from GERMANY Additional patient health information: Female patient , 79 years of age, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type), coronary artery disease (What is coronary artery disease?) and. Omeprazole dosage: . During the same period patient was treated with METOPROLOL SUCCINATE (Daily Dose: 95 Mg Millgram(s) Every Days) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HCT (View Hct Review and Hct Label ), CORIFEO (View Corifeo Review and Corifeo Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).